FDA-approved Stem Cell Trial Dramatically Slows ALS

For an unheard-of two years, stem cells have slowed the progression of Lou Gehrig's disease, a devastating condition with a two-to-five year survival rate, in a small group of patients.

http://www.biosciencetechnology.com/articles/2013/05/fda-approved-stem-cell-trial-dramatically-slows-als